US Stock MarketDetailed Quotes

BWAY Brainsway

Watchlist
  • 9.800
  • -0.040-0.41%
Trading Nov 22 10:27 ET
184.07MMarket Cap122.50P/E (TTM)

About Brainsway Company

Brainsway Ltd. engages in the development and sale of non-invasive neurostimulation treatments using the proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) technology for the treatment of major depressive disorder (MDD) and obsessive-compulsive disorder (OCD). The Deep TMS uses magnetic pulses to stimulate neurons and consequently modulates the physiological activity of the brain. The company was founded by Avner Hagai, Yiftach Roth, Abraham Zangen, and David Zacut on November 7, 2006 and is headquartered in Jerusalem, Israel.

Company Profile

SymbolBWAY
Company NameBrainsway
Listing DateApr 17, 2019
Issue Price11.00
Founded2006
CEOMr. Hadar Levy
MarketNASDAQ
Employees106
Securities TypeDR
ADS Ratio1.0 : 2.0
Fiscal Year Ends12-31
AddressBynet Building,19 Hartum Street, 3rd Floor,Har Hotzvim
CityJerusalem
ProvinceJerusalem
CountryIsrael
Zip Code9777518
Phone972-2-582-4030

Company Executives

  • Name
  • Position
  • Salary
  • Hadar Levy
  • Chief Executive Officer
  • 606.00K
  • Ido Marom
  • Chief Financial Officer
  • --
  • Christopher Boyer
  • Vice President of Global Marketing
  • 337.00K
  • Moria Ankri
  • Vice President of Research and Development
  • 241.00K
  • Colleen Hanlon, PhD
  • Vice President of Medical Affairs
  • 306.00K
  • Dr. David Zacut
  • Vice Chairman of the Board
  • 35.79K
  • Amiram Boehm
  • Chairman of the Board
  • 147.87K
  • Professor Abraham Zangen
  • Director
  • 72.18K
  • Eti Mitrany
  • Independent Director
  • 58.66K
  • Avner Hagai
  • Independent Director
  • 43.65K
  • Yossi Ben Shalom
  • Independent Director
  • 42.12K
  • Karen Sarid
  • Independent Director
  • 56.99K
  • Avner Lushi
  • Independent Director
  • 55.61K
  • Dr. Yiftach Roth
  • Chief Scientist
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data